Treatment of Right Heart Failure in Pulmonary Heart Disease

Jan 15, 2022 Source: Cainiu Health
Dr. Liu Aifen
Introduction
Pulmonary heart disease (cor pulmonale) refers to a clinical syndrome resulting from chronic pulmonary disease, which leads to right ventricular enlargement and subsequent abnormalities in right ventricular systolic and diastolic function. Systemic venous congestion is commonly observed; its primary manifestation is generalized edema, most prominently affecting the lower extremities and dependent body areas.

Pulmonary heart disease (cor pulmonale) refers to a clinical syndrome resulting from chronic pulmonary disorders that lead to right ventricular enlargement and subsequent impairment of right ventricular systolic and diastolic function. A hallmark manifestation is systemic venous congestion, most commonly presenting as generalized edema—particularly prominent in the lower extremities and dependent body areas.

Treatment of Right Heart Failure in Pulmonary Heart Disease

Other underlying pulmonary conditions contributing to cor pulmonale include thoracic deformities, pulmonary tuberculosis, and pulmonary fibrosis. Treatment comprises two main components: first, management of the underlying chronic pulmonary disease—the most common cause being chronic obstructive pulmonary disease (COPD); second, targeted therapy for right heart failure.

Therapy for right heart failure primarily focuses on anti-infective treatment. If significant edema is present, diuretics may be selectively employed; however, diuretic use is typically adjunctive rather than primary—the cornerstone remains effective antimicrobial therapy. In select cases, positive inotropic agents may also be considered.

In chronic cor pulmonale complicated by right heart failure, management emphasizes symptomatic control. Prevention of infection—especially pulmonary infection—is paramount. Commonly used antibiotics include cephalosporins and penicillins; however, antibiotic selection should ideally be guided by culture and sensitivity testing to ensure optimal pathogen coverage. Specific pharmacotherapy for heart failure—including inotropes and diuretics—must be administered strictly under physician supervision.

Dietary considerations are critical for patients with right heart failure. Excessive salt and fatty foods must be avoided, as they can increase blood viscosity. Regular, appropriate physical activity promotes systemic circulation, enhances vital capacity, and improves pulmonary function. Particularly for COPD patients, dietary recommendations emphasize low sugar intake, high protein, and high vitamin content.

We hope the above information is helpful to you. Wishing you a healthy and joyful life!